Dr. Ferruccio Palazzesi, SOM Biotech Senior Computational Chemist, attended the International Symposium on “Rare diseases and big data, from research to clinical practice”, organized by Bioinformatics Barcelona Association (BIB) and Fundación Ramon Areces. Event took place in Barcelona 26-27th October 2017. The symposium covered clinical management of rare diseases, as well as current research and…

Using the latest modular workflow technologies, SOM Biotech has released a new version of his proprietary drug repurposing virtual process. This update has had the goal to improve more than 30% the performance, scalability and velocity of the process. This software update highlights the SOM Biotech strong commitment to grow day-by-day, in order to continue…

SOM Biotech has determined and validated an entirely new usage for Nippon Chemiphar’s marketed hypertension therapy bevantolol (Calvan®). SOM, after using a proprietary ligand analysis computational algorithm and completing the preclinical assays, determined that bevantolol (coded SOM3355 by SOM) is a highly effective Vesicular Monoamine Transporter Type 2 (VMAT2) inhibitor, a class of compounds that…

SOM Biotech was one of the presenting companies at 2017 ASEBIO Investor Day. ASEBIO Investor Day is an event which allows Spanish innovative biotechnology projects to be introduced to an audience of leading investors and pharmaceutical companies. The event is organized by ASEBIO, the Spanish Bioindustry Association, with the support of ICEX - the Spanish Foreign Trade…

SOM Biotech was one of the companies invited to the Private Chinese-Swiss Investor Collaborations Forum that took place in Zurich on September 11th 2017. Dr. Insa (CEO) and Dr. Palazzesi (Senior Computational Chemist) were in charge to present Company’s Strategy and Assets to the large Chinese delegation interested in knowing and investing in health-care EU companies.…

La Compañía SOM Biotech estuvo presente en el II Workshop sobre Transferencia del Conocimiento Científico en la Distrofia Muscular de Duchenne que se llevó a cabo el pasado día 7 de Septiembre de 2017, día Mundial de dicha enfermedad. Las sesiones tuvieron lugar en el Aula de Grados de la Facultad de Biología de la UB, y en las…